Herman S Overkleeft Selected Research

Antigens

2/2021	Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens.
1/2019	Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen.
11/2016	The Optimization of Bioorthogonal Epitope Ligation within MHC-I Complexes.
4/2007	Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herman S Overkleeft Research Topics

Disease

30	Neoplasms (Cancer) 01/2023 - 06/2007
22	Gaucher Disease (Gaucher's Disease) 11/2021 - 02/2007
13	Multiple Myeloma 01/2023 - 05/2011
9	Fabry Disease (Fabry's Disease) 01/2018 - 06/2011
5	Type 2 Diabetes Mellitus (MODY) 10/2021 - 01/2009
5	Inflammation (Inflammations) 01/2021 - 01/2012
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019 - 01/2012
3	Glycogen Storage Disease Type II (Pompe's Disease) 08/2023 - 05/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 04/2015
3	Obesity 12/2015 - 08/2014
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2021
2	Neuroblastoma 01/2022 - 08/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Infections 01/2020 - 04/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2019 - 09/2016
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 12/2018
2	Colitis 12/2018 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 12/2018 - 12/2016
2	Globoid Cell Leukodystrophy (Krabbe Disease) 01/2017 - 02/2016
2	Alzheimer Disease (Alzheimer's Disease) 12/2016 - 12/2014
2	Pneumonia (Pneumonitis) 10/2015 - 03/2011
2	Insulin Resistance 01/2012 - 01/2010
2	Pathologic Processes 01/2009 - 02/2007
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Glycogen Storage Disease (Glycogenosis) 08/2023
1	Plasma Cell Leukemia 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Carcinogenesis 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Transfusion Reaction 12/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021
1	Rheumatoid Arthritis 02/2021

Drug/Important Bio-Agent (IBA)

13	Proteasome InhibitorsIBA 01/2022 - 01/2012
12	Glucosylceramidase (Glucocerebrosidase)IBA 11/2021 - 12/2010
10	EnzymesIBA 01/2023 - 12/2015
10	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 04/2014
7	GlucosidasesIBA 01/2022 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2008
7	GlycosphingolipidsIBA 12/2019 - 02/2007
5	Bortezomib (Velcade)FDA Link 10/2021 - 05/2011
5	LipidsIBA 01/2021 - 01/2014
4	AnthracyclinesIBA 01/2023 - 01/2020
4	carfilzomibIBA 01/2023 - 05/2011
4	cyclophellitolIBA 01/2022 - 05/2016
4	AntigensIBA 02/2021 - 04/2007
4	Peptides (Polypeptides)IBA 01/2021 - 06/2007
4	LigandsIBA 01/2021 - 06/2015
4	Glucosylceramides (Glucocerebrosides)IBA 11/2019 - 04/2015
4	sphingosyl beta-glucosideIBA 11/2019 - 04/2015
4	GalactosidasesIBA 01/2018 - 08/2014
4	ceramide glucosyltransferaseIBA 03/2016 - 02/2007
4	Peptide Hydrolases (Proteases)FDA Link 10/2015 - 05/2003
3	heparanaseIBA 01/2023 - 08/2017
3	miglustat (Zavesca)FDA Link 01/2022 - 02/2007
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2020
3	Polysaccharides (Glycans)IBA 01/2020 - 03/2011
3	ProgranulinsIBA 01/2019 - 09/2016
2	ChromatinIBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	GlucuronidaseIBA 01/2023 - 08/2017
2	ixazomibIBA 10/2021 - 10/2018
2	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021 - 03/2017
2	Conjugate VaccinesIBA 10/2020 - 01/2019
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 12/2019
2	AcidsIBA 01/2020 - 05/2016
2	Glycoside Hydrolases (Endoglycosidases)IBA 12/2019 - 11/2014
2	VaccinesIBA 01/2019 - 03/2017
2	HydrolasesIBA 01/2019 - 08/2014
2	CeramidesIBA 12/2018 - 01/2016
2	EndocannabinoidsIBA 01/2018 - 04/2015
2	Psychosine (Galactosylsphingosine)IBA 01/2017 - 02/2016
2	GlycolipidsIBA 12/2015 - 05/2005
2	Matrix Metalloproteinases (MMPs)IBA 10/2015 - 01/2015
2	TrypsinIBA 04/2014 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 03/2013 - 06/2011
1	AndrogensIBA 11/2023
1	Cysteine (L-Cysteine)FDA Link 11/2023
1	Androgen Receptors (Androgen Receptor)IBA 11/2023
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022
1	human GAA protein (Myozyme)FDA Link 01/2022
1	wobeIBA 01/2022
1	Starch (Cornstarch)IBA 10/2021
1	Amylases FDA Link 10/2021
1	OvalbuminIBA 02/2021
1	VinculinIBA 02/2021
1	Histones (Histone)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Nelfinavir (Viracept)FDA Link 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Membrane LipidsIBA 01/2021
1	major vault proteinIBA 01/2021

Therapy/Procedure

14	Therapeutics 08/2023 - 08/2014
2	Immunotherapy 01/2021 - 04/2007
2	Enzyme Replacement Therapy 03/2016 - 03/2013